MedPath

Comparison of The Success Rates of Four Different Pulpotomy Techniques

Phase 3
Completed
Conditions
Extensive Decay in Primary Molars
Interventions
Drug: ProRoot (Aggregate)
Drug: Biodentine
Registration Number
NCT03135626
Lead Sponsor
Istanbul University
Brief Summary

This randomized clinical trial was conducted to examine and compare the effectiveness of pulpotomy in primary molars treated with calcium silicate based materials including Biodentine and two different mineral trioxide aggregate (MTA) products (white ProRoot® MTA and MTA Plus®). Ferric sulfate pulpotomy was selected to represent the control group. 116 primary molars in 29 children were treated by pulpotomy and followed for a period of 24 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
38
Inclusion Criteria
  • Patients were eligible if they were 5 to 7 years old, healthy and cooperative, and had at least four carious primary molars, each of which was in a different quadrant and required a pulpotomy. The criteria for the selection of the teeth to be included in the study were presence of deep caries, presence of at least two-thirds of the root length radiographically and being restorable.
Exclusion Criteria
  • The exclusion criteria were the presence of any clinical or radiographic evidence of pulp degeneration (spontaneous or nocturnal tooth pain, tenderness to percussion, pathological mobility, internal or external root resorption, swelling or fistula, widened periodontal ligament (PDL) space, furcal or periapical radiolucency and teeth requiring more than 5 minutes to achieve hemostasis during clinical procedure. Teeth without permanent successor were not also included in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ProRoot MTAProRoot (Aggregate)ProRoot MTA pulpotomy agent
MTA PlusMTA PlusMTA Plus pulpotomy agent
Ferric Sulfate 20% Dental GelFerric Sulfate 20 % Dental GelFerric Sulfate %20 Dental Gel pulpotomy agent
BiodentineBiodentineBiodentine pulpotomy agent
Primary Outcome Measures
NameTimeMethod
Total success rate24 months after pulpotomy treatment

Number of molars with both clinically and radiographically successful

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath